STRS Ohio’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-583
Closed -$202K 2260
2021
Q4
$202K Buy
583
+493
+548% +$191K ﹤0.01% 1738
2021
Q3
$30K Buy
+90
New +$46.1K ﹤0.01% 2140

Other funds holding OMIC

STRS Ohio's OMIC Position: Q1 2022 in Review

STRS Ohio sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2022, closing a stake of 583 shares — an estimated $202K sold.

STRS Ohio first reported a position in OMIC in Q3 2021 and held it in 2 quarters. The position peaked at $202K in Q4 2021. 69 funds tracked by Wall St. Rank hold OMIC as of Q1 2022.

  • STRS Ohio reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • STRS Ohio sold 583 Singular Genomics Systems, Inc. Common Stock shares in Q1 2022, an estimated $202K.
  • STRS Ohio first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • STRS Ohio's Singular Genomics Systems, Inc. Common Stock position peaked at $202K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2022.

Based on STRS Ohio's 13F filing for Q1 2022, filed 21 Apr 2022.